Xiamen Amoytop Biotech Co Ltd Sustainability Reports
The company engages in the research, development, production, and marketing of recombinant protein drugs and biological products. It primarily targets treatments for viral hepatitis, malignant tumors, and immunotherapy applications.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00NQM44D5
2 reports from 2024 to 2025